These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29518757)

  • 1. Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome.
    Lazaridou S; Dinas K; Tziomalos K
    Hormones (Athens); 2017 Oct; 16(4):373-380. PubMed ID: 29518757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method.
    Lerchbaum E; Schwetz V; Giuliani A; Obermayer-Pietsch B
    Hum Reprod; 2013 Sep; 28(9):2537-44. PubMed ID: 23756702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and predictors of postpartum glucose intolerance in Italian women with gestational diabetes mellitus.
    Capula C; Chiefari E; Vero A; Foti DP; Brunetti A; Vero R
    Diabetes Res Clin Pract; 2014 Aug; 105(2):223-30. PubMed ID: 24931701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study.
    Kazemi Jaliseh H; Ramezani Tehrani F; Behboudi-Gandevani S; Hosseinpanah F; Khalili D; Cheraghi L; Azizi F
    Fertil Steril; 2017 Dec; 108(6):1078-1084. PubMed ID: 29202960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome.
    Velija-Asimi Z; Burekovic A; Dujic T; Dizdarevic-Bostandzic A; Semiz S
    Bosn J Basic Med Sci; 2016 Nov; 16(4):298-306. PubMed ID: 27648989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of a positive family history of both type 2 diabetes and PCOS on metabolic and endocrine parameters in a large cohort of PCOS women.
    Lerchbaum E; Schwetz V; Giuliani A; Obermayer-Pietsch B
    Eur J Endocrinol; 2014 May; 170(5):727-39. PubMed ID: 24591551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
    Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
    PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediabetes and diabetes in a cohort of Qatari women screened for polycystic ovary syndrome.
    Dargham SR; Shewehy AE; Dakroury Y; Kilpatrick ES; Atkin SL
    Sci Rep; 2018 Feb; 8(1):3619. PubMed ID: 29483674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis.
    Long C; Feng H; Duan W; Chen X; Zhao Y; Lan Y; Yue R
    Front Endocrinol (Lausanne); 2022; 13():980405. PubMed ID: 36120432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
    Tomlinson J; Millward A; Stenhouse E; Pinkney J
    Diabet Med; 2010 May; 27(5):498-515. PubMed ID: 20536945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of type 2 diabetes is increased in nonobese women with polycystic ovary syndrome: the National Health Insurance Service-National Sample Cohort Study.
    Ryu KJ; Kim MS; Kim HK; Kim YJ; Yi KW; Shin JH; Hur JY; Kim T; Park H
    Fertil Steril; 2021 Jun; 115(6):1569-1575. PubMed ID: 33509630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and the Risk of Infertility, Gestational Diabetes, and Type 2 Diabetes in Polycystic Ovary Syndrome.
    Pirotta S; Joham A; Grieger JA; Tay CT; Bahri-Khomami M; Lujan M; Lim SS; Moran LJ
    Semin Reprod Med; 2020 Nov; 38(6):342-351. PubMed ID: 33873233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression to prediabetes or diabetes in young Korean women with polycystic ovary syndrome: A longitudinal observational study.
    Choi YM; Hwang KR; Oh SH; Lee D; Chae SJ; Yoon SH; Kim JJ
    Clin Endocrinol (Oxf); 2021 May; 94(5):837-844. PubMed ID: 33440048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.
    Celik C; Tasdemir N; Abali R; Bastu E; Yilmaz M
    Fertil Steril; 2014 Apr; 101(4):1123-8.e1. PubMed ID: 24502891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
    Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
    Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome--a management update.
    Costello MF
    Aust Fam Physician; 2005 Mar; 34(3):127-33. PubMed ID: 15799658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of type 2 diabetes mellitus compared between lean and overweight/obese patients with polycystic ovarian syndrome: a 5-year follow-up study.
    Chantrapanichkul P; Indhavivadhana S; Wongwananuruk T; Techatraisak K; Dangrat C; Sa-Nga-Areekul N
    Arch Gynecol Obstet; 2020 Mar; 301(3):809-816. PubMed ID: 31927625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovary syndrome and metabolic comorbidities: therapeutic options.
    De Leo V; Musacchio MC; Palermo V; Di Sabatino A; Morgante G; Petraglia F
    Drugs Today (Barc); 2009 Oct; 45(10):763-75. PubMed ID: 20069140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of glucose metabolism abnormalities in Greek women with polycystic ovary syndrome.
    Trakakis E; Basios G; Peppa M; Simeonidis G; Labos G; Creatsa M; Misailidou M; Boutati E; Vaggopoulos V; Panagopoulos P; Dimitriades G; Kassanos D
    Gynecol Endocrinol; 2012 Nov; 28(11):867-70. PubMed ID: 22571176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for dysglycaemia by oral glucose tolerance test should be recommended in all women with polycystic ovary syndrome.
    Li HW; Lam KS; Tam S; Lee VC; Yeung TW; Cheung PT; Yeung WS; Ho PC; Ng EH
    Hum Reprod; 2015 Sep; 30(9):2178-83. PubMed ID: 26202923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.